Peculiarities of phytotherapy of diabetes mellitus through the prism of comorbidity and prevention of complications (review of literature)

Main Article Content

O.I. Voloshin
O.V. Glubochenko
I.V. Pankiv
V.G. Glubochenko
N.M. Malkovich


The article presents the modern literature data about phytotherapy of patients with diabetes mellitus through the prism of comorbid processes and the prevention of complications. The article focuses on the review of the plant components that responsible for hypoglycemic action. Target ways of herbal influence are discussed, as well as the basic principles and pathogenetic mechanisms of the pharmacological effects of phytotherapy in diabetes mellitus. It is emphasized on the complexity of anti-glycemic action, which is due to the interaction of various substances. The authors further focused on the individual representatives of medicinal plants that are most often used in the treatment of diabetes, in particular, Vaccinium myrtillus L., Galega officinalis L., Phaseolus vulgaris L., Sambucus nigra L., Aralia mandshurica, Taraxacum officinale Wigg., Inula helenium L., Linum usitatissimum L., Momordica charantia, Gymnema sylvestre, Trigonella foenum graecu, Ginkgo biloba. The main combined preparations, antidiabetic phytospecies composition, dietary supplements, which are presented on the pharmaceutical market of Ukraine, are considered. The main approaches to the use of herbal medicines and their role in the treatment and long-term rehabilitation of patients with diabetes are highlighted. The necessity of carrying out scientific researches on creating polycomponent herbal medicine with multipurpose action and improving treatment and preventive measures by means of phytotherapy are emphasized.

Article Details

How to Cite
Voloshin, O., O. Glubochenko, I. Pankiv, V. Glubochenko, and N. Malkovich. “Peculiarities of Phytotherapy of Diabetes Mellitus through the Prism of Comorbidity and Prevention of Complications (review of Literature)”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 15, no. 3, July 2019, pp. 258-67, doi:10.22141/2224-0721.15.3.2019.172113.
Literature Review


Pankiv VI. Diabetes mellitus: definition, classification, epidemiology, risk factors. Mìžnarodnij endokrinologìčnij žurnal. 2013;7(55):95-104. doi: 10.22141/2224-0721.7.55.2013.84685. (in Ukrainian).

Kaiser AB, Zhang N, van der Pluijm W. Global prevalence of type 2 diabetes over the next ten years (2018-2028). Diabetes. 2018;67(suppl 1):

International Diabetes Federation (IDF). IDF Diabetes Atlas 2017. 8th ed. Brussels, Belgium: International Diabetes Federation; 2017. 150 p.

Fadieienko GD, Nesen AO. Comorbidity and integration role of therapy of internal diseases. Ukrainian Therapeutical Journal. 2015;(2):7-15. (in Ukrainian).

American Diabetes Association. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes - 2019. Diabetes Care. 2019 Jan;42(Suppl 1):S34-S45. doi: 10.2337/dc19-S004.

World Health Organization (WHO). WHO Traditional Medicine Strategy 2014 - 2023. Geneva, Switzerland: WHO Press; 2013. 76 p.

Voloshyn OI, Vasjuk VL, Voloshyna LO, Malkovych NM, Senjuk BP, Glubochenko OV, authors; Voloshyn OI, editor. Osnovy fitoterapii' i gomeopatii' [Basics of herbal medicine and homeopathy]. 2nd ed. Chernivtsi: Misto; 2017. 608 p. (in Ukrainian).

Nazarian-Samani Z, Sewell RDE, Lorigooini Z, Rafieian-Kopaei M. Medicinal Plants with Multiple Effects on Diabetes Mellitus and Its Complications: a Systematic Review. Curr Diab Rep. 2018 Aug 13;18(10):72. doi: 10.1007/s11892-018-1042-0.

Bashar Saad, Hilal Zaid, Siba Shanak, Slemen Kadan. Anti-diabetes and Anti-obesity Medicinal Plants and Phytochemicals: Safiety, Efficiacy, and Action Mechanisms. Cham, Switserland: Springer; 2017. 265 p. doi: 10.1007/978-3-319-54102-0.

Chekman IS, Bondur VV, Klymenko OV. Combined pharmacotherapy of type 2 diabetes mellitus. Ratsionalnaya farmakoterapiya. 2016;2(39):25-31. (in Ukrainian).

Ota A, Ulrih NP. An Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes. Front Pharmacol. 2017 Jul 6;8:436. doi: 10.3389/fphar.2017.00436.

Rybak VA, Maloshtan LN. Experimental study hypoglycemic activity of plants extracts. Ukraïns’kij bìofarmacevtičnij žurnal 2013;(29):42-45. (in Ukrainian).

Ning C, Wang X, Gao S, et al. Chicory inulin ameliorates type 2 diabetes mellitus and suppresses JNK and MAPK pathways in vivo and in vitro. Mol Nutr Food Res. 2017 Aug;61(8). doi: 10.1002/mnfr.201600673.

Samal L, Chaturvedi VB, Saikumar G, Somvanshi R, Pattanaik AK. Prebiotic potential of Jerusalem artichoke (Helianthus tuberosus L.) in Wistar rats: effects of levels of supplementation on hindgut fermentation, intestinal morphology, blood metabolites and immune response. J Sci Food Agric. 2015 Jun;95(8):1689-96. doi: 10.1002/jsfa.6873.

Guo J, Wang J, Song S, et al. Sphallerocarpus gracilis polysaccharide protects pancreatic β-cells via regulation of the bax/bcl-2, caspase-3, pdx-1 and insulin signalling pathways. Int J Biol Macromol. 2016 Dec;93(Pt A):829-836. doi: 10.1016/j.ijbiomac.2016.08.083.

Niu CS, Chen LJ, Niu HS. Antihyperglycemic action of rhodiola-aqeous extract in type1-like diabetic rats. BMC Complement Altern Med. 2014 Jan13;14:20. doi: 10.1186/1472-6882-14-20.

Jin D, Zhao T, Feng WW, et al. Schisandra polysaccharide increased glucose consumption by up-regulating the expression of GLUT-4. Int J Biol Macromol. 2016 Jun;87:555-62. doi: 10.1016/j.ijbiomac.2016.03.028.

Ahn J, Um MY , Lee H, Jung CH, Heo SH, Ha TY. Eleutheroside E, An Active Component of Eleutherococcus senticosus, Ameliorates Insulin Resistance in Type 2 Diabetic db/db Mice. Evid Based Complement Alternat Med. 2013;2013:934183. doi: 10.1155/2013/934183.

Bharti SK, Krishnan S, Kumar A, Kumar A. Antidiabetic phytoconstituents and their mode of action on metabolic pathways. Ther Adv Endocrinol Metab. 2018 Mar;9(3):81-100. doi: 10.1177/2042018818755019.

Aniszewski T. Alkaloids: chemistry, biology, ecology, and applications. 2nd ed . Amsterdam: Elsevier; 2015. 496 p.

Gupta PD, De A. Diabetes Mellitus and its herbal treatment. IJMRPS. 2012;3(2):706-721.

Sidorova Y, Shipelin V, Mazo V, Zorin S, Petrov N, Kochetkova A. Hypoglycemic and hypolipidemic effect of Vaccinium myrtillus L. leaf and Phaseolus vulgaris L. seed coat extracts in diabetic rats. Nutrition. 2017 Sep;41:107-112. doi: 10.1016/j.nut.2017.04.010.

Karcheva-Bahchevanska DP, Lukova PK, Nikolova MM, Mladenov RD, Iliev IN. Effect of Extracts of Bilberries (Vaccinium myrtillus L.) on Amyloglucosidase and α-Glucosidase Activity. Folia Med (Plovdiv). 2017 Jun 1;59(2):197-202. doi: 10.1515/folmed-2017-0028.

Bljajić K, Petlevski R, Vujić L, et al. Chemical Composition, Antioxidant and α-Glucosidase-Inhibiting Activities of the Aqueous and Hydroethanolic Extracts of Vaccinium myrtillus Leaves. Molecules. 2017 Apr 28;22(5). pii: E703. doi: 10.3390/molecules22050703.

Luka CD, Adoga GI, Istifanus G. Phytochemical Studies of Different Fractions of Galega officinalis Extract and Their Effects on Some Biochemical Parameters in Alloxan-Induced Diabetic Rats. European Journal of Medicinal Plants. 2017;19(1):1-10. doi: 10.9734/EJMP/2017/32145.

Korsun VF, Trumpe TE, Korsun EV, Ershov NV, Ogrenich NA. Fitoterapiia protiv diabeta. Travy zhizni [Herbal medicine against diabetes. Grass of life]. Moscow: Tsentrpoligraf; 2016. 390 p. (in Russian).

Barchuk OZ, Lysiuk RM, Denys AI, Zaliska OM, Smalyuh OG, Nester MI. Experimental study of goat’s rue (Galega Officinalis L.) herb and its liquid extracts. Pharma Innovation Journal. 2017;6(11):393-397.

Khokhla M, Кleveta G, Lupak M, et al. Studies of Galega officinalis extract component. Visnyk of Lviv University. Biological series. 2013;(62):55-60. (in Ukrainian).

Kurylo KhI, Klishch IM. Comparative effect of pharmaceuticals on the basis of Galega Officinalis on the biochemical indicators in the blood of animals with type 2 experimental diabetes mellitus. Medicna i klinicna himia. 2017;19(3):35-41. doi 10.11603/mcch.2410-681X.2017.v0.i3.8200. (in Ukrainian).

Lupak MI, Khokhla MR, Hachkova GYa, et al. The alkaloid-free fraction from Galega officinalis extract prevents oxidative stress under experimental diabetes mellitus . Ukr Biochem J. 2015;87(4):78-86. doi: 10.15407/ ubj87.04.078. (in Ukrainian).

Vronska LV, Tymoftevych NZ, Ezhned MA, Barchuk OZ. Review of plants which exhibit hypoglicemic activity. Pharmaceutical Review. 2013;(2):142-148. doi: 10.11603/2312-0967.2013.2.2404. (in Ukrainian).

Almuaigel MF, Seif MA, Albuali HW, Alharbi O, Alhawash A. Hypoglycemic and hypolipidemic effects of aqueous extract of phaseolus vulgaris pods in streptozotocin-diabetic rats. Biomed Pharmacother. 2017 Oct;94:742-746. doi: 10.1016/j.biopha.2017.07.135.

Nuñez-Aragón PN, Segura-Campos M, Negrete-León E, et al. Protein hydrolysates and ultrafiltered < 1 KDa fractions from Phaseolus unatus, Phaseolus vulgaris and Mucuna pruriens exhibit antihyperglycemic activity, intestinal glucose absorption and α-glucosidase inhibition with no acute toxicity in rodents. J Sci Food Agric. 2019 Jan 30;99(2):587-595. doi: 10.1002/jsfa.9219.

Ulbricht C, Basch E, Cheung L, et al. An Evidence-Based Systematic Review of Elderberry and Elderflower (Sambucus nigra) by the Natural Standard Research Collaboration. J Diet Suppl. 2014 Mar;11(1):80-120. doi: 10.3109/19390211.2013.859852.

Salvador ÂC, Król E, Lemos VC, et al. Effect of Elderberry (Sambucus nigra L.) Extract Supplementation in STZ-Induced Diabetic Rats Fed with a High-Fat Diet. Int J Mol Sci. 2016 Dec 22;18(1). pii: E13. doi: 10.3390/ijms18010013.

Shikov AN, Pozharitskaya ON, Makarov VG. Aralia elata var. mandshurica (Rupr. & Maxim.) J.Wen: An overview of pharmacological studies. Phytomedicine. 2016 Nov 15;23(12):1409-1421. doi: 10.1016/j.phymed.2016.07.011.

Kim YS, Kim M, Choi MY, et al. Aralia elata (Miq) Seem Extract Decreases O-GlcNAc Transferase Expression and Retinal Cell Death in Diabetic Mice. J Med Food. 2017 Oct;20(10):989-1001. doi: 10.1089/jmf.2016.3891.

Hwang KA, Hwang YJ, Kim GR, Choe JS. Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity. BMC Complement Altern Med. 2015 Oct 5;15:347. doi: 10.1186/s12906-015-0871-5.

Wirngo FE, Lambert MN, Jeppesen PB. The Physiological Effects of Dandelion (Taraxacum Officinale) in Type 2 Diabetes. Rev Diabet Stud. 2016 Summer-Fall;13(2-3):113-131. doi: 10.1900/RDS.2016.13.113.

Mir MA, Sawhney SS, Jassal MM. In-vitro antidiabetic studies of various extracts of Taraxacum officinale. Pharma Innov. 2015;4(1):61-66.

Seca AM, Grigore A, Pinto DC, Silva AM. The genus Inula and their metabolites: from ethnopharmacological to medicinal uses. J Ethnopharmacol. 2014 Jun 11;154(2):286-310. doi: 10.1016/j.jep.2014.04.010.

Chun J, Li RJ, Cheng MS, Kim YS. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells. Cancer Lett. 2015 Feb 1;357(1):393-403. doi: 10.1016/j.canlet.2014.11.049.

Kim M, Song K, Kim YS. Alantolactone Improves Prolonged Exposure of Interleukin-6-Induced Skeletal Muscle Inflammation Associated Glucose Intolerance and Insulin Resistance. Front Pharmacol. 2017 Jun 29;8:405. doi: 10.3389/fphar.2017.00405.

Kaur N, Kishore L, Singh R. Therapeutic effect of Linum usitatissimum L. in STZ-nicotinamide induced diabetic nephropathy via inhibition of AGE's and oxidative stress. J Food Sci Technol. 2017 Feb;54(2):408-421. doi: 10.1007/s13197-016-2477-4.

Baek HJ, Jeong YJ, Kwon JE, Ra JS, Lee SR, Kang SC. Antihyperglycemic and Antilipidemic Effects of the Ethanol Extract Mixture of Ligularia fischeri and Momordica charantia in Type 2 Diabetes-Mimicking Mice. Evid Based Complement Alternat Med. 2018 Oct 2;2018:3468040. doi: 10.1155/2018/3468040.

Jia S, Shen M, Zhang F, Xie J. Recent Advances in Momordica charantia: Functional Components and Biological Activities. Int J Mol Sci. 2017 Nov 28;18(12). pii: E2555. doi: 10.3390/ijms18122555.

Joseph B, Jini D. Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac J Trop Dis. 2013;3(2):93-102. doi:10.1016/S2222-1808(13)60052-3.

Chaturvedi P. Antidiabetic potentials of Momordica charantia: multiple mechanisms behind the effects. J Med Food. 2012 Feb;15(2):101-7. doi: 10.1089/jmf.2010.0258.

Tsai CH, Chen EC, Tsay HS, Huang CJ. Wild bitter gourd improves metabolic syndrome: a preliminary dietary supplementation trial. Nutr J. 2012 Jan 13;11:4. doi: 10.1186/1475-2891-11-4.

Shih CC, Shlau MT, Lin CH, Wu JB. Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and AMPK phosphorylation in high-fat-fed mice. Phytother Res. 2014 Mar;28(3):363-71. doi: 10.1002/ptr.5003.

Efird JT, Choi YM, Davies SW, Mehra S, Anderson EJ, Katunga LA. Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes. Int J Environ Res Public Health. 2014 Feb 21;11(2):2328-45. doi: 10.3390/ijerph110202328.

Jiang B, Ji M, Liu W, Chen L, Cai Z, Zhao Y. Antidiabetic activities of a cucurbitane-type triterpenoid compound from Momordica charantia in alloxan-induced diabetic mice. Mol Med Rep. 2016 Nov;14(5):4865-4872. doi: 10.3892/mmr.2016.5800.

Tiwari P, Ahmad K, Baig MH. Gymnema sylvestre for Diabetes: From Traditional Herb to Future’s Therapeutic. Curr Pharm Des. 2017;23(11):1667-1676. doi: 10.2174/1381612823666161108162048.

Kumar V, Bhandari U, Tripathi CD, Khanna G. Protective effect of Gymnema sylvestre ethanol extract on high fat diet-induced obese diabetic wistar rats. Indian J Pharm Sci. 2014 Jul;76(4):315-22.

Shenoy RS, Prashanth KVH, Manonmani HK. In Vitro Antidiabetic Effects of Isolated Triterpene Glycoside Fraction from Gymnema sylvestre. Evid Based Complement Alternat Med. 2018 Aug 8;2018:7154702. doi: 10.1155/2018/7154702.

Nagulapalli Venkata KC, Swaroop A, Bagchi D, Bishayee A. A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion. Mol Nutr Food Res. 2017 Jun;61(6). doi: 10.1002/mnfr.201600950.

Fuller S, Stephens JM. Diosgenin, 4-hydroxyisoleucine, and fiber from fenugreek: mechanisms of actions and potential effects on metabolic syndrome. Adv Nutr. 2015 Mar 13;6(2):189-97. doi: 10.3945/an.114.007807.

Jiang W, Si L, Li P, et al. Serum metabonomics study on antidiabetic effects of fenugreek flavonoids in streptozotocin-induced rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 15;1092:466-472. doi: 10.1016/j.jchromb.2018.06.041.

Pradeep SR, Srinivasan K. Alleviation of oxidative stress-mediated nephropathy by dietary fenugreek (Trigonella foenum-graecum) seeds and onion (Allium cepa) in streptozotocin-induced diabetic rats. Food Funct. 2018 Jan 24;9(1):134-148. doi: 10.1039/c7fo01044c.

Aziz TA, Hussain SA, Mahwi TO, Ahmed ZA. Efficacy and safety of Ginkgo biloba extract as an "add-on" treatment to metformin for patients with metabolic syndrome: a pilot clinical study. Ther Clin Risk Manag. 2018 Jul 11;14:1219-1226. doi: 10.2147/TCRM.S169503.

Zhu CY, Yi Q, Ma JL, Wei QP. Clinical evaluation of Ginkgo biloba extract for diabetic retinopathy. International Journal of Ophthalmology. 2016;16(2):361-364 doi: 10.3980/j.issn.1672-5123.2016.2.45.

Tian J, Liu Y, Chen K. Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications. Curr Vasc Pharmacol. 2017;15(6):532-548. doi: 10.2174/1570161115666170713095545.

Most read articles by the same author(s)

<< < 1 2 3 4 > >>